Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2013
10/08/2013US8551977 Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
10/08/2013US8551974 Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
10/08/2013US8551542 Methods and compositions for increasing growth hormones
10/08/2013US8551522 Sustained-release formulation
10/08/2013US8551515 Pharmacokinetics of S-adenosylmethionine formulations
10/08/2013US8551501 Chitin microparticles and their medical uses
10/08/2013US8551498 Solid composition containing Bacillus-type non-pathogenic bacterial spores
10/08/2013CA2730714C Factor viii polymer conjugates
10/08/2013CA2678575C Compounds having a cyclic moiety and compositions for delivering active agents
10/08/2013CA2614987C Method for preparing polymer maleimides
10/08/2013CA2591419C Water-dispersible xanthan gum containing composition
10/08/2013CA2542898C Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
10/08/2013CA2495048C Hemostatic compositions and devices
10/08/2013CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
10/03/2013WO2013149237A1 Targeting intracellular organelle zip codes with functional homing ligands from cell-internalizing phage combinatorial libraries
10/03/2013WO2013149190A1 Pharmaceutical compositions and methods for treatment of fungal infections
10/03/2013WO2013149159A1 Anti-lgr5 antibodies and immunoconjugates
10/03/2013WO2013148682A1 Methods and compositions for controlled delivery of phytochemical agents
10/03/2013WO2013148579A1 Pegylated c-peptide
10/03/2013WO2013148405A2 Treatment for atherosclerosis
10/03/2013WO2013148376A1 Acoustically responsive particles
10/03/2013WO2013148259A1 Cancer-related extracellular matrix signatures and related methods and products
10/03/2013WO2013148258A1 Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
10/03/2013WO2013148186A1 Lipid-coated nucleic acid nanostructures of defined shape
10/03/2013WO2013148174A1 New anti-mycobacterial drugs against tuberculosis
10/03/2013WO2013148158A1 Laser-actuated therapeutic nanoparticles
10/03/2013WO2013147921A1 Polyvinylpyrrolidone-containing acetaminophen liquid formulations
10/03/2013WO2013147645A1 Method for producing drugs and biologically active agents
10/03/2013WO2013147618A1 Ionophore antibiotic suspension
10/03/2013WO2013147451A1 Pharmaceutical composition containing branched chain amino acid, and production method therefor
10/03/2013WO2013147329A1 Composition for enteric hard capsule and enteric hard capsule prepared using the composition
10/03/2013WO2013147135A1 Controlled-release pharmaceutical composition
10/03/2013WO2013147134A1 Mirabegron-containing pharmaceutical composition
10/03/2013WO2013147125A1 Drug intake enhancer
10/03/2013WO2013147072A1 Cocrystal of 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen-1-one
10/03/2013WO2013147000A1 Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid
10/03/2013WO2013146917A1 Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose
10/03/2013WO2013146840A1 Paste-like composition and method for producing same
10/03/2013WO2013146772A1 Method for producing additive for erythrocyte concentrate, and drug filling bag
10/03/2013WO2013146687A1 Composition comprising s-adenosylmethionine and/or salt thereof
10/03/2013WO2013146649A1 Diquafosol-containing eye drop
10/03/2013WO2013146471A1 Drug composition, and soft capsule containing same
10/03/2013WO2013146376A1 Coating composition and medical device
10/03/2013WO2013145870A1 Aqueous dispersed composition
10/03/2013WO2013145750A1 Capsule pharmaceutical preparation
10/03/2013WO2013145749A1 Capsule preparation
10/03/2013WO2013145379A1 Capsule disintegrable in large-intestine-specific manner
10/03/2013WO2013144604A1 Biotinidase resistant biotinyl compounds
10/03/2013WO2013144412A1 System for conveying antigenic molecules in recombinant polymers similar to elastin
10/03/2013WO2013144369A1 Material, method for preparing same, and uses thereof
10/03/2013WO2013144356A1 Steroid, in particular a progestin, comicronized with a polymer having the pyrrolidone group, and compositions and uses
10/03/2013WO2013144341A1 Microsphere compositions, preparation method and applications thereof
10/03/2013WO2013143891A1 Nicotine formulation
10/03/2013WO2013143890A1 Oral administration
10/03/2013WO2013143549A1 Benzene polycarboxylic acid compounds and their use as drug
10/03/2013WO2013143323A1 Application of gastrodin as solubilizer and method for preparing injection or powder for injection
10/03/2013WO2013143322A1 Method for dissolving flavonoid compound, carbon glycoside compound, or stilbene compound and method for preparing injection or powder for injection
10/03/2013WO2013143300A1 Sustained-release preparation of fulvestrant or derivatives thereof and preparation method therefor
10/03/2013WO2013143299A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
10/03/2013WO2013143298A1 Fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
10/03/2013WO2013142996A1 Magnesium phosphate gels
10/03/2013WO2013142961A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
10/03/2013WO2012156527A9 Pharmaceutical composition having improved bioavailability
10/03/2013US20130261593 Device, System, and Method for Delivery of Sugar Glass Stabilized Compositions
10/03/2013US20130261592 Liquid pharmaceutical formulations of palonosetron
10/03/2013US20130261195 Micronized starch and methods for manufacturing same
10/03/2013US20130261194 Functionalized Water-Soluble Polyphosphazenes and Uses Thereof as Modifiers of Biological Agents
10/03/2013US20130261192 Medical absorbable hemostatic material for bone wounds and preparation method therefor
10/03/2013US20130261179 Stabilised Prostaglandin Composition
10/03/2013US20130261173 Cyclodextrin-based polymers for therapeutic delivery
10/03/2013US20130261166 Methods and compositions for treating neurological disease
10/03/2013US20130261156 Pharmaceutical composition
10/03/2013US20130261150 Liquid pharmaceutical formulations of palonosetron
10/03/2013US20130261149 Liquid pharmaceutical formulations of palonosetron
10/03/2013US20130261145 Pharmaceutical formulation containing gelling agent
10/03/2013US20130261144 Pharmaceutical Formulation Containing Gelling Agent
10/03/2013US20130261143 Pharmaceutical Formulation Containing Gelling Agent
10/03/2013US20130261126 Brimonidiine gel compositions and methods of use
10/03/2013US20130261097 Pharmaceutical composition and method for treating hypogonadism
10/03/2013US20130261096 Formulation For Hormonotherapy
10/03/2013US20130261094 Tunable, biodegradable linker molecules for transient conjugation of components in drug delivery systems, and drug delivery systems prepared therewith
10/03/2013US20130261092 Method of synergistically enhancing the therapeutic efficacy and safety of medication through a combination therapy
10/03/2013US20130261091 Salicylic Acid Gel
10/03/2013US20130261072 Oligomer conjugates of heteropentacyclic nucleosides
10/03/2013US20130260398 Phosphohistidine analogs
10/03/2013US20130259942 Particulate substances comprising ceramic particles for delivery of biomolecules
10/03/2013US20130259935 Pharmaceutical compositions comprising glimepiride and polyethylene glycol castor oil
10/03/2013US20130259882 Conjugate of Folate and Antibody Preparation Method and Use Thereof
10/03/2013US20130259862 Antibody-mediated transduction of heat shock proteins into living cells
10/03/2013US20130259860 Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
10/02/2013EP2644622A1 Micronized starch and methods for manufacturing same
10/02/2013EP2644206A2 PEG derivatives containing two PEG chains
10/02/2013EP2644189A1 Stable bortezomib formulations
10/02/2013EP2643396A1 Method for coating particles with calcium phosphate and particles, microparticles and nanoparticles formed thereof
10/02/2013EP2643382A2 Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization
10/02/2013EP2643372A2 Stealth polymeric particles for delivery of bioactive or diagnostic agents
10/02/2013EP2643363A1 Process for the preparation of low-peroxide crosslinked vinyllactam polymer
10/02/2013EP2643057A1 An implant for the controlled release of pharmaceutically active agents
10/02/2013EP2643022A1 Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
10/02/2013EP2643021A1 Binding drugs with nanocrystalline cellulose (ncc)
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 1712